[Hyperlipoproteinemia type II].
D000293:Adolescent; D000328:Adult; D002432:Cecum / Q000601:surgery; D002648:Child; D002791:Cholesterol, Dietary / Q000009:adverse effects; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000175:diagnosis; D003918:Dextrothyroxine / Q000627:therapeutic use; D004032:Diet; D004359:Drug Therapy, Combination; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D007082:Ileum / Q000601:surgery; D008077:Lipoproteins, LDL / Q000097:blood; D009355:Neomycin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010956:Plasmapheresis; D011167:Portacaval Shunt, Surgical; D014972:Xanthogranuloma, Juvenile / Q000175:diagnosis
D002791:Cholesterol, Dietary; D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D002994:Clofibrate; D009355:Neomycin
Hyperlipoproteïnemie type II.